Testicular cancer clinical practice guidelines in oncology

Robert J. Motzer; Graeme B. Bolger; Barry Boston; Michael A. Carducci; Mayer Fishman; Steven L. Hancock; Ralph J. Hauke; Gary R. Hudes; Eric Jonasch; Philip Kantoff; Timothy M. Kuzel; Paul H. Lange; Ellis G. Levine; Chris Logothetis; Kim A. Margolin; Kamal S. Pohar; Bruce G. Redman; Cary N. Robertson; Wolfram E. Samlowski; Joel Sheinfeld

doi:10.6004/jnccn.2006.0087

Testicular cancer clinical practice guidelines in oncology

Robert J. Motzer, Graeme B. Bolger, Barry Boston, Michael A. Carducci, Mayer Fishman, Steven L. Hancock, Ralph J. Hauke, Gary R. Hudes, Eric Jonasch, Philip Kantoff, Timothy M. Kuzel, Paul H. Lange, Ellis G. Levine, Chris Logothetis, Kim A. Margolin, Kamal S. Pohar, Bruce G. Redman, Cary N. Robertson, Wolfram E. Samlowski, Joel Sheinfeld

School of Medicine

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

An estimated 8250 new cases of testicular cancer will be diagnosed in the United States in 2006, with germ cell tumors (GCTs) constituting 95% of the malignant tumors arising in the testes. Although GCTs are relatively uncommon tumors, they are the most common solid tumor in men between the ages of 15 and 34 years. The worldwide incidence of these tumors has more than doubled in the past 40 years. More than 90% of all patients diagnosed with GCTs are cured, including 70% to 80% of patients with advanced tumors who are treated with chemotherapy. Standard therapy has been established at essentially all stages of management and must be closely followed to ensure the potential for cure.

Original language	English (US)
Pages (from-to)	1038-1058
Number of pages	21
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	4
Issue number	10
DOIs	https://doi.org/10.6004/jnccn.2006.0087
State	Published - Nov 2006

Keywords

Alpha-fetoprotein
Cisplatin
Germ cell tumors
Human chorionic gonadotropin
Lactate dehydrogenase
NCCN clinical practice guidelines
Nonseminoma
Seminoma
Testicular cancer

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2006.0087

Cite this

Motzer, R. J., Bolger, G. B., Boston, B., Carducci, M. A., Fishman, M., Hancock, S. L., Hauke, R. J., Hudes, G. R., Jonasch, E., Kantoff, P., Kuzel, T. M., Lange, P. H., Levine, E. G., Logothetis, C., Margolin, K. A., Pohar, K. S., Redman, B. G., Robertson, C. N., Samlowski, W. E., & Sheinfeld, J. (2006). Testicular cancer clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 4(10), 1038-1058. https://doi.org/10.6004/jnccn.2006.0087

Motzer, RJ, Bolger, GB, Boston, B, Carducci, MA, Fishman, M, Hancock, SL, Hauke, RJ, Hudes, GR, Jonasch, E, Kantoff, P, Kuzel, TM, Lange, PH, Levine, EG, Logothetis, C, Margolin, KA, Pohar, KS, Redman, BG, Robertson, CN, Samlowski, WE & Sheinfeld, J 2006, 'Testicular cancer clinical practice guidelines in oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 4, no. 10, pp. 1038-1058. https://doi.org/10.6004/jnccn.2006.0087

@article{30fcd1c61818484d84856fe7f4f9e018,

title = "Testicular cancer clinical practice guidelines in oncology",

abstract = "An estimated 8250 new cases of testicular cancer will be diagnosed in the United States in 2006, with germ cell tumors (GCTs) constituting 95% of the malignant tumors arising in the testes. Although GCTs are relatively uncommon tumors, they are the most common solid tumor in men between the ages of 15 and 34 years. The worldwide incidence of these tumors has more than doubled in the past 40 years. More than 90% of all patients diagnosed with GCTs are cured, including 70% to 80% of patients with advanced tumors who are treated with chemotherapy. Standard therapy has been established at essentially all stages of management and must be closely followed to ensure the potential for cure.",

keywords = "Alpha-fetoprotein, Cisplatin, Germ cell tumors, Human chorionic gonadotropin, Lactate dehydrogenase, NCCN clinical practice guidelines, Nonseminoma, Seminoma, Testicular cancer",

author = "Motzer, {Robert J.} and Bolger, {Graeme B.} and Barry Boston and Carducci, {Michael A.} and Mayer Fishman and Hancock, {Steven L.} and Hauke, {Ralph J.} and Hudes, {Gary R.} and Eric Jonasch and Philip Kantoff and Kuzel, {Timothy M.} and Lange, {Paul H.} and Levine, {Ellis G.} and Chris Logothetis and Margolin, {Kim A.} and Pohar, {Kamal S.} and Redman, {Bruce G.} and Robertson, {Cary N.} and Samlowski, {Wolfram E.} and Joel Sheinfeld",

year = "2006",

month = nov,

doi = "10.6004/jnccn.2006.0087",

language = "English (US)",

volume = "4",

pages = "1038--1058",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "10",

}

TY - JOUR

T1 - Testicular cancer clinical practice guidelines in oncology

AU - Motzer, Robert J.

AU - Bolger, Graeme B.

AU - Boston, Barry

AU - Carducci, Michael A.

AU - Fishman, Mayer

AU - Hancock, Steven L.

AU - Hauke, Ralph J.

AU - Hudes, Gary R.

AU - Jonasch, Eric

AU - Kantoff, Philip

AU - Kuzel, Timothy M.

AU - Lange, Paul H.

AU - Levine, Ellis G.

AU - Logothetis, Chris

AU - Margolin, Kim A.

AU - Pohar, Kamal S.

AU - Redman, Bruce G.

AU - Robertson, Cary N.

AU - Samlowski, Wolfram E.

AU - Sheinfeld, Joel

PY - 2006/11

Y1 - 2006/11

N2 - An estimated 8250 new cases of testicular cancer will be diagnosed in the United States in 2006, with germ cell tumors (GCTs) constituting 95% of the malignant tumors arising in the testes. Although GCTs are relatively uncommon tumors, they are the most common solid tumor in men between the ages of 15 and 34 years. The worldwide incidence of these tumors has more than doubled in the past 40 years. More than 90% of all patients diagnosed with GCTs are cured, including 70% to 80% of patients with advanced tumors who are treated with chemotherapy. Standard therapy has been established at essentially all stages of management and must be closely followed to ensure the potential for cure.

AB - An estimated 8250 new cases of testicular cancer will be diagnosed in the United States in 2006, with germ cell tumors (GCTs) constituting 95% of the malignant tumors arising in the testes. Although GCTs are relatively uncommon tumors, they are the most common solid tumor in men between the ages of 15 and 34 years. The worldwide incidence of these tumors has more than doubled in the past 40 years. More than 90% of all patients diagnosed with GCTs are cured, including 70% to 80% of patients with advanced tumors who are treated with chemotherapy. Standard therapy has been established at essentially all stages of management and must be closely followed to ensure the potential for cure.

KW - Alpha-fetoprotein

KW - Cisplatin

KW - Germ cell tumors

KW - Human chorionic gonadotropin

KW - Lactate dehydrogenase

KW - NCCN clinical practice guidelines

KW - Nonseminoma

KW - Seminoma

KW - Testicular cancer

UR - http://www.scopus.com/inward/record.url?scp=33751585163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751585163&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2006.0087

DO - 10.6004/jnccn.2006.0087

M3 - Article

C2 - 17112452

AN - SCOPUS:33751585163

SN - 1540-1405

VL - 4

SP - 1038

EP - 1058

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 10

ER -

Testicular cancer clinical practice guidelines in oncology

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this